Effectiveness of systemic treatments for advanced non-clear cell renal cell carcinoma: a systematic review and meta-analysis
BackgroundNon-clear cell renal cell carcinoma (nccRCC) represents a heterogeneous group of malignancies with substantial differences in morphology, genetic profiles, clinical behavior, and prognosis. Optimal treatment for nccRCC remains unclear, largely extrapolated from evidence available for clear...
Saved in:
| Main Authors: | Yaping Zhang, Jian Chen, Xiaoyan Wang, Hui Wang, Xiaoli Chen, Jianfeng Hong, Hongming Fang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1478245/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapies in Refractory Metastatic Renal Cell Carcinoma
by: Stephanie Berg, et al.
Published: (2022-11-01) -
Management of Toxicity and Side Effects of Systemic Therapy for Renal Cell Carcinoma
by: Kate Young, et al.
Published: (2022-11-01) -
SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma
by: Xianglai Xu, et al.
Published: (2024-12-01) -
Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
by: Joohyun Hong, et al.
Published: (2024-03-01) -
Prognostic and Therapeutic Implications of Alamandine Receptor MrgD Expression in Clear Cell Renal Cell Carcinoma with Development of Metastatic Disease
by: Gorka Larrinaga, et al.
Published: (2025-03-01)